ACTR Reading Tools
How to cite item
The third-generation EGFR TKI osimertinib could be a promising neoadjuvant therapy in patients with resectable EGFR-mutant NSCLC
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{ACTR}{8777}, author = {Karasaki, T.}, title = {The third-generation EGFR TKI osimertinib could be a promising neoadjuvant therapy in patients with resectable EGFR-mutant NSCLC}, journal = {AME Clinical Trials Review}, volume = {2}, number = {0}, year = {2024}, url = {https://actr.amegroups.org/article/view/8777} }